News

Neal Buchalter, MBA, president of Parker Laboratories, spoke with Infection Control Today® in an exclusive interview about the product, the companies involved, and how it came to the US market.

AstraZeneca's new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.

As an oversight agency for the Department of Health and Human Services, the Office of Inspector General is responsible for ensuring the safety and effectiveness of Medicare and Medicaid programs, with a huge priority being patient care. These toolkits provide additional guidance on how to avoid patient injury.

In his analysis, Kevin Kavanagh, MD, explores the measures taken by the infectious disease sector in response to the pandemic, pointing out both effective and ineffective approaches. He also discusses how the pandemic has affected the treatment of other infectious diseases.

A small study explored the connection between Postural Orthostatic Tachycardia Syndrome (POTS) and the COVID-19 condition.

A session held at the APIC 2023 Annual Conference & Exhibition delved into the importance of equity in infection prevention and explored the impact of health inequities on the transmission of diseases.

Investigators studied 2 infants experiencing seizures, small head size, and developmental delays born of mothers who had contracted COVID-19 during pregnancy.

Legionnaires’ disease is a severe infection and fatal in 10% of cases.

Establishing a permanent system for monitoring the persistence and emergence of dangerous pathogens is necessary, especially COVID-19.

Saskia v. Popescu, PhD, MPH, MA, CIC, gives the latest on COVID-19, Marburg Virus Disease, and a 1-hit STI antibiotic plan.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending April 23, 2023.

Sulbactam-durlobactam is under priority review (PDUFA; May 29, 2023). 

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending April 2, 2023.

Despite the recent CDC warning and frightening media coverage, understanding which patients are at a higher risk of Candida auris is important too. The lead author of the recent CDC's study spoke to ICT's sister brand for further insights on the threat.

Saskia v. Popescu, PhD, MPH, MA, CIC, gives the latest on Candida auris, Marburg Virus Disease, and eye drops from EzriCare and Delsam Pharma.

Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in health care facilities today.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending March 5, 2023.

Week of March 1, 2023, Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the hottest topics in infection prevention and control. This week it is the Marburg Virus, COVID-19 origins, and avian (bird) flu.

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the latest in the artificial tears infection alert and in the bird flu—and good news for COVID-19—for February 10, 2023.

Experts from around the world shared new data about cryptococcus at the recent International Conference on Cryptococcus & Cryptococcosis (ICCC) in Uganda.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 3, 2023.

EzriCare Artificial Tears have been linked to a multistate cluster of VIM‐GES‐CRPA associated with multiple different types of infections, including eye infections, permanent vision loss, hospitalizations, and 1 death.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 27, 2023.

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the latest in COVID-19, a CDC shake-up, and the bird flu.

Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in health care facilities today.

Moderna announced encouraging news about its RSV mRNA-1345 vaccine and plans to submit for regulatory approval in the first half of 2023.

The public expects infectious disease experts to know how to protect them—and themselves—from getting ill from infectious diseases, including COVID-19. So, what happens when the infectious disease specialist gets ill herself?

A study from Canada suggests that not being vaccinated for COVID-19 could mean an individual is at higher risk for an automobile accident. What if it is from brain damage from contracting COVID-19?